Genomics and cancer

Current Opinion in Oncology

Volumn 14, Issue 1, 2002, Pages 79-85

  Onyango, Patrick ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER GENETICS; CANCER RESEARCH; DNA MICROARRAY; DNA SEQUENCE; GENE THERAPY; GENOMICS; HUMAN; HUMAN CELL; PHARMACOGENETICS; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

GENE THERAPY; GENOMICS; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; PHARMACOGENETICS; PROTEOME;

EID: 0036148992     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200201000-00014     Document Type: Review

References (75)

1. Initial sequencing and analysis of the human genome
2. The sequence of the human genome
3. Transcriptional profiling in cancer: The path to clinical pharmacogenomics
4. Functional genomics: It's all how you read it
5. Pharmacogenetics initiative galvanizes public and private sectors
6. Genome maintenance mechanisms for preventing cancer
7. Cancer genetics
8. At the interfaces of epidemiology, genetics and genomics
9. Hypomethylation distinguishes genes of some human cancers from their normal counterparts
10. Methylation meets genomics
11. Genome and genetic resources from the Cancer Genome Anatomy Project
12. Cancer andgenomics
13. Comparative genomics of the eukaryotes
14. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons
15. Sequence and comparative analysis of the mouse 1-megabase region orthologous to the human 11 p15 imprinted domain
16. Introducing defined chromosomal rearrangements into the mouse genome
17. Human cancer syndromes: Clues to the origin and nature of cancer
18. Genetic testing for cancer risk
19. A strong candidate for the breast and ovarian-cancer susceptibility gene brca1
20. Has the breast-cancer gene been found
21. P53 mutations in human cancers
22. The neu oncogene: An erb-b-related gene encoding a 185,000-mr tumor-antigen
23. Sarcoma growth-factor from conditioned medium of virally transformed-cells is composed of both type-alpha and type-beta transforming growth-factors
24. Isolation of human mdr-DNA sequences amplified in multidrug-resistant kb carcinoma-cell
25. The role of surgery and postopoerative chemoradiation therapy in patients with lymph node positive esophageal carcinoma
26. Best supportive care in non-small cell lung cancer: Is there a role for radiotherapy and chemotherapy?
27. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
28. Single-nucleotide polymorphisms in the public domain: How useful are they?
29. Quantitative monitoring of gene-expression patterns with a complementary-DNA microarray
30. High density synthetic oligonucleotide arrays
31. Gene expression profiling: Monitoring transcription and translation products using DNA microarrays and proteomics
32. Yeast microarrays for genome wide parallel genetic and gene expression analysis
33. When the chips are down
34. Transcription, genomes, function
35. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
36. Distinct types of diffuse large b-cell lymphoma identified by gene expression profiling
37. Tissue microarrays for high-throughput molecular profiling of tumor specimens
38. Tissue microarray technology for high-throughput molecular profiling of cancer
39. Serial analysis of gene-expression
40. Minisage: Gene expression profiling using serial analysis of gene expression from 1 μg total rna
41. Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma
42. Proteomics in cancer research
43. Cancer proteomics: From identification of novel markers to creation of artificial learning models for tumor classification
44. Cancer proteomics: From biomarker discovery to signal pathway profiling
45. Proteomics: A new approach to the study of disease
46. Recent developments in computational proteomics
47. Proteomics: A technology-driven and technology-limited discovery science
48. Tissue-specific microdissection coupled with proteinchip (r) array technologies: Applications in cancer research
49. Protein biochips for differential profiling
50. The 2-hybrid system: A method to identify and clone genes for proteins that interact with a protein of interest
51. Mips: A database for genomes and protein sequences
52. Detecting protein function and protein-protein interactions from genome sequences
53. A comprehensive analysis of protein-protein interactions in saccharomyces cerevisiae
54. A comprehensive two-hybrid analysis to explore the yeast protein interactome
55. A visual intracellular classification strategy for uncharacterized human proteins
56. Functional interaction of p53 and blm DNA helicase in apoptosis
57. Rna as a target of double-stranded rna-mediated genetic interference in caenorhabditis elegans
58. Rna-triggered gene silencing
59. Potent and specific genetic interference by double-stranded rna in caenorhabditis elegans
60. Use of dsrna-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway
61. The evolutionarily conserved bmp-binding protein twisted gastrulation promotes bmp signalling
62. Selective reduction of dormant maternal mrnas in mouse oocytes by rna interference
63. Specific interference with gene function by double-stranded rna in early mouse development
64. Duplexes of 21-nucleotide rnas mediate rna interference in cultured mammalian cells
65. Rna interference is mediated by 21- and 22-nucleotide rnas
66. A novel functional genomics approach identifies mtert as a suppressor of fibroblast transformation
67. Identification of id4 as a regutator of brca1 expression by using a ribozyme-library-based inverse genomics approach
68. What will be the role of pharmacogenetics in evaluating drug safety and minimizing adverse effects?
69. Fused transcript of abl and bcr genes in chronic myelogenous leukemia
70. Sti 571 induces apoptosis of bcr-abl positive cells in-vitro: The roles of caspase 3, 9 and TRA
71. Gene therapy: A molecular approach to cancer treatment
72. Manipulation of human minichromosomes to carry greater than megabase-sized chromosome inserts
73. Gene therapy: Trials and tribulations